Skip to main content

Table 1 Laboratories on the first admission

From: SGLT2 inhibitor in a type 2 diabetes mellitus patient coexisted with central diabetes insipidus following hyperosmolar hyperglycemic state

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us